Vir Biotechnology and GlaxoSmithKline’s investigational monoclonal antibody product called Sotrovimab (Vir-7831) was authorized today by the UAE’s health ministry given the experimental product’s efficacy treating…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.